{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:45:27Z","timestamp":1772084727579,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.bpobgyn.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T21:54:57Z","timestamp":1339710897000},"page":"757-768","source":"Crossref","is-referenced-by-count":27,"title":["Management of anovulatory infertility"],"prefix":"10.1016","volume":"26","author":[{"given":"Raymond Hang Wun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2012.05.004_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1258\/0007142001903283","article-title":"Infertility and the establishment of pregnancy \u2013 overview","volume":"56","author":"Templeton","year":"2000","journal-title":"Br Med Bull"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib2","series-title":"WHO manual for the standardized investigation and diagnosis of the infertile couple","author":"Rowe","year":"1997"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib3","series-title":"The polycystic ovary syndrome: guidance for diagnosis and management","author":"Balan","year":"2006"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1210\/jc.83.5.1507","article-title":"Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/humrep\/deh118","article-title":"Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data?","volume":"19","author":"Lass","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/humrep\/deh110","article-title":"Assessment of ovarian reserve. Is there still a role for ovarian biopsy? First do no harm!","volume":"19","author":"Sharara","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/5.5.483","article-title":"Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy","volume":"5","author":"van Karsteren","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib9","first-page":"119","article-title":"Macroprolactin-a cause of pseudohyperprolactinaemia","volume":"9","author":"Yuen","year":"2003","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/humupd\/dmk003","article-title":"Nutrition and reproduction in women","volume":"12","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib13","first-page":"50","article-title":"Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta analysis","volume":"7","author":"Mulders","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1467-789X.2007.00406.x","article-title":"The impact of obesity on female reproductive function","volume":"8","author":"Metwally","year":"2007","journal-title":"Obesity Rev"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.fertnstert.2007.07.1290","article-title":"Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence","volume":"90","author":"Metwally","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmn043","article-title":"Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis","volume":"15","author":"Nieuwenhuis-Ruifrok","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2265.1990.tb00899.x","article-title":"A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205\u2013502, with bromocriptine in women with hyperprolactinaemia","volume":"32","author":"Homburg","year":"1990","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1012884214668","article-title":"Quinagolide in the management of prolactinoma","volume":"3","author":"Schultz","year":"2000","journal-title":"Pituitary"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199614040-00003","article-title":"A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation","volume":"14","author":"Webster","year":"1996","journal-title":"Drug Safety"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bpobgyn.2007.08.002","article-title":"Hyperprolactinaemia","volume":"22","author":"Prabhakar","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib25","series-title":"Drug safety update 3","year":"2008"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jc.2009-2095","article-title":"Potential cardiac valve effects of dopamine agonists in hyperprolactinemia","volume":"95","author":"Valassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0015-0282(16)60964-0","article-title":"The effect of therapy initiation day on clomiphene citrate therapy","volume":"52","author":"Wu","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib28","series-title":"Fertility: assessment and treatment for people with fertility problems","year":"2004"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib29","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate \u2013 end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib30","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.ajog.2005.02.072","article-title":"Use of micro-dose human chorionic gonadotropin (hCG) after clomiphene citrate to complete folliculogenesis in previous CC-resistant anovulation","volume":"192","author":"Branigan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.fertnstert.2005.09.018","article-title":"Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function","volume":"85","author":"Yilmaz","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib32","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00003081-200012000-00020","article-title":"Ovulation induction","volume":"43","author":"Wolf","year":"2000","journal-title":"Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib33","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/humrep\/deh840","article-title":"Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis","volume":"20","author":"Steiner","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib34","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"1","author":"Tang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a meta-analysis","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","article-title":"The role of metformin in polycystic ovary syndrome: a systematic review","volume":"13","author":"Moll","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.fertnstert.2007.02.062","article-title":"Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2005.05.078","article-title":"A new era in ovulation induction","volume":"85","author":"Holzer","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: a systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00016340802638199","article-title":"Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility","volume":"88","author":"Badawy","year":"2009","journal-title":"Acta Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib42","doi-asserted-by":"crossref","first-page":"1199.e9","DOI":"10.1016\/j.fertnstert.2007.08.065","article-title":"Triplet pregnancy after ovulation induction with an aromatase inhibitor","volume":"90","author":"Dicken","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1096-9926(199909)60:3<143::AID-TERA9>3.0.CO;2-#","article-title":"Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous","volume":"60","author":"Bishai","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.fertnstert.2004.01.006","article-title":"Aromatase inhibitors and teratogenesis","volume":"81","author":"Tiboni","year":"2004","journal-title":"Fertil Steril"},{"issue":"Supp. 1","key":"10.1016\/j.bpobgyn.2012.05.004_bib45","first-page":"O-231","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib46","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0015-0282(16)54113-2","article-title":"Life table analysis of fecundity in intravenously gonadotropin-releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea","volume":"55","author":"Braat","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09513598909152450","article-title":"Pregnancy outcome in luteinizing hormone-releasing hormone induced cycles: a multicentre study","volume":"3","author":"Braat","year":"1989","journal-title":"J Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.298.6676.809","article-title":"One hundred pregnancies after treatment with pulsatile luteinsing hormone releasing hormone to induce ovulation","volume":"298","author":"Homburg","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1210\/jc.79.4.1215","article-title":"Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles","volume":"79","author":"Filicori","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib51","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0015-0282(16)54715-3","article-title":"Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients","volume":"56","author":"Shoham","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib52","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/humrep\/der401","article-title":"Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study","volume":"27","author":"Homburg","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumours in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib55","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittermore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.AOG.0000119226.39514.1d","article-title":"Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis","volume":"103","author":"Kashyap","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib57","doi-asserted-by":"crossref","first-page":"b249","DOI":"10.1136\/bmj.b249","article-title":"Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study","volume":"338","author":"Jensen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib58","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/humrep\/17.4.1046","article-title":"Laparoscopic ovarian diathermy in women with polycystic ovarian syndrome: a retrospective study on the influence of the amount of energy used on the outcome","volume":"17","author":"Amer","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib59","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/humrep\/deg307","article-title":"A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy","volume":"18","author":"Amer","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/humrep\/den325","article-title":"Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome","volume":"24","author":"Amer","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2012.05.004_bib61","first-page":"CD001122","article-title":"Laparoscopic \u2018drilling\u2019 by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","volume":"3","author":"Farquhar","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T20:22:41Z","timestamp":1542918161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693412000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1521693412000909"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2012.05.004","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}